PolarityTE, Inc. is a clinical-stage biotechnology company that develops and commercializes a range of regenerative tissue products and biomaterials for the medical, biomedical engineering and materials science markets in the United States.
PolarityTE’s Platform Develops Autologous Products: PolarityTE's platform technology harnesses natural regeneration and enables cells to function as they normally do in the body. Through its revolutionary platform, the company aims to induce cell-tissue polarity and create functional tissue. The company's goal is to apply the platform to all cells, tissues and structures and make regenerative medicine what it has been envisioned to be since its inception. The platform also enables the development of products that are autologous - from the patient for the patient.
Skinte® Was Developed to Overcome the Limitations of Current Treatments: The company offers SkinTE, which features: autologous and engrafted healthy new tissue for the wound, contains cell types and matrix from all skin layers needed for healing, rapid manufacturing and ease of use allows for use in all patients, and is designed as a single application.
The Values of the Company Are Determined by Its Medical Foundations: PolarityTE is a company founded by providers for providers and the patients they serve. The founders gave up their medical practice in order to serve more patients on a larger scale. Patients, providers and the advancement of all humanity are at the heart of the company's work. PolarityTE is committed to upholding the highest ethical, professional and legal standards as a member of the medical and global community.
Industry: Business & Industrial > Pharmaceuticals & Biotech
More information about PolarityTE
|Address||StreetAddress: 1960 S 4250th W, AddressLocality: Salt Lake City, AddressRegion: Utah, PostalCode: 84104, AddressCountry: United States|
|Number Of Employees||59|
|Ticker Symbol||NASDAQ: PTE|
New York City, US
14 Sep 2023